【摘 要】
:
Platelet-rich plasma (PRP) containing autologous thrombocyte growth factors is applied in regenerative medicine, but the lack of an optimized PRP preparation protocol causes unstable therapeutic effec
【机 构】
:
Ph.D Program in Nutrition & Food Science, Graduate Institute of Basic Medicine, Fu Jen Catholic Univ
【出 处】
:
GTAUF2014 & APSMHA2014第六届长城泌尿男科转化医学论坛暨第七届亚太男性健康与抗衰老研究学会年会
论文部分内容阅读
Platelet-rich plasma (PRP) containing autologous thrombocyte growth factors is applied in regenerative medicine, but the lack of an optimized PRP preparation protocol causes unstable therapeutic effects.The aim of this study was to optimize the PRP preparation method to obtain the largest amount of growth factors released and compare the effects of PRP from different preparation methods in restoring of erectile function in bilateral cavernous nerve (CN) injury rat model.The in vivo experiments used Sprague-Dawley male rats (n=24) which were randomly divided into four groups of equal numbers: (Ⅰ) sham operation;(Ⅱ) vehicle only (which underwent bilateral nerve crushing without treatment);(Ⅲ) general PRP;and (Ⅳ) optimized PRP containing the largest amount of platelet-derived growth factor (PDGF)-AB (groups 3 and 4 underwent bilateral CN crushing with an immediate injection of the respective PRP into the corpus cavernosum).The intracavernous pressure (ICP) of all rats was monitored.Results demonstrated that in the PRP group prepared with the anticoagulant, ACD-A, the amount of PDGF-AB released was statistically higher than those of the other groups (P<0.05).Greater concentrations of PDGF-AB were measured in PRP after chitosan treatment compared to treatment with a solvent or other activating factors.Additionally, storing PRP at-20 ℃ resulted in a significant increase in PDGF-AB released compared to storage at other temperatures.The optimized PRP prepared by stimulation with chitosan and incubated at-20 ℃ for 15 days had the largest amount of PDGF-AB and showed a synergistic effect on release (P<0.05).The functional outcome measurement revealed improvement after bilateral CN injury occurred in the group treated with optimized PRP.It was concluded that optimized PRP with a high level of growth factors was more stable, and its injection into the corpus cavernosum facilitated recovery of erectile function.
其他文献
目的:研究布地奈德福莫特罗(信必可)或沙美特罗替卡松(舒利迭)吸入与氨茶碱片口服治疗缓解期COPD患者的临床效果差别.方法:取2012年2月-2013年9月在张家港市中医院门诊就诊的186例缓解期COPD患者,根据干预药物不同,随机分3组:信必可组、舒利迭组以及氨茶碱片组,每组62例,信必可组(160/4.5微克)吸入,每次2吸,bid.舒利迭组(50/250微克)吸入,每次1吸,bid.氨茶碱片
目的:探讨健康教育路径在慢性阻塞性肺疾病(COPD)住院患者护理中的应用效果.方法:将我科60例COPD患者随机分为对照组和观察组各30例.对照组采用常规健康教育模式,观察组进行健康评估,设计健康教育路径表,应用路径表对患者实施健康教育.结果:观察组健康知识掌握、呼吸功能锻炼正确率高于对照组(P<0.05,P<0.01),患者满意度高于对照组(P<0.05).
目的:金养麦提取物对慢性阻塞性肺病(COPD)大鼠模型的疗效及机制.方法:水提和醇提法制备金荞麦提取物;改良烟熏法复制SD大鼠COPD模型,分为正常组,模型组,金养麦水提取物低、高剂量组,金荞麦醇提取物低、高剂量组;药物干预后,放射免疫法测定血清肿瘤坏死因子(TNF-a)、白介素-6(IL-6)、白介素-8(IL-8)、Ⅲ型前胶原肽(PⅢ)、转化生长因子(TGF-β 1)含量的变化,光镜观察肺组织
Objectives: The aim of this study was to assess the predictive value of survival in patients with advanced non small cell lung cancer (NSCLC) treated with cisplatin-based first-line chemotherapy.Metho
目的:探讨慢性阻塞性肺疾病(COPD)急性加重期(AECOPD)患者治疗前后诱导痰中a-防御素1-3(HNP1-3)含量、中性粒细胞比例(N%)与肺功能及血气分析结果的相关性,以探讨HNP1-3在COPD发病机制中的可能作用.方法:收集AECOPD患者42例(根据肺功能检测结果分为轻度组11例、中度组13例、重度组18例)治疗前后及20例急性支气管炎痊愈者(对照组)的诱导痰,分别进行痰中性粒细胞计
目的:通过对肺结核患者外周血和支气管肺泡灌洗液中CD4+CD25+Treg细胞的分析,探讨其在肺结核患者中的临床意义.方法:采用流式细胞技术多色荧光分析法,测定100例肺结核患者及50例健康体检者外周血和支气管肺泡灌洗液中CD4+CD25+Treg细胞水平,观察肺结核患者与健康对照者之间、治疗前后及结核杆菌阳性与阴性者之问的差别.
目的:通过对肺结核患者外周血和支气管肺泡灌洗液中T淋巴细胞亚群的分析,探讨其在肺结核患者中的临床意义.方法:采用流式细胞技术多色荧光分析法,测定50例肺结核患者及50例健康体检者外周血和支气管肺泡灌洗液中T淋巴细胞亚群水平,观察肺结核患者与健康对照者之间和治疗前后的差别.结果:结核病患者外周血和支气管灌洗液中的CD3+、CD4+和CD4+/CD8+T细胞绝对值明显低于正常人,而CD8+升高(P<0
目的:对高分子量(M v =4×105~5×105)的聚对二氧环己酮(PPDO)制成的PDS(直径USP 2)在模拟不同pH值的人体内环境下(如呼吸道)进行体外降解行为的研究.方法:我们设定三大组,分别为溶液pH值=1.2组;溶液pH=7.4组;溶液pH=8.5组.取样品分别浸于不同pH值的磷酸缓冲溶液(PBS)中,并置于恒温震荡器中,调节温度至37℃,按浸泡时间分别于2、4、6、8、10、12周
目的:总结南京鼓楼医院确诊的3例肺泡微石症患者的临床表现、影像学、病理及相关辅助检查, 以探讨肺泡微石症(PAM)的临床特点.方法:回顾性分析3例肺泡微石症患者的症状体征、肺功能、影像学及病理检查,并综合相关文献报道.结果:3例患者中均有咳嗽,2例伴有胸闷气喘,无肺部体征,血常规、肝肾功能、钙磷检测未见异常,肺功能提示3例弥散功能降低,2例有限制性通气功能减退;影像学均可见弥漫性高密度结节,中下肺
Object: To establish rapid diagnosis of pulmonary TB by the detection of IgG and IgM antibodies raised against the target recombinant protein (ESAT-6、 CFP-10、 ESPC、 14KD/38KD and ESAT-6/14KD/38KD).Met